Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
CRISPR–Cas9 Structures and Mechanisms
2017 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Dealing with the unexpected: consumer responses to direct-access BRCA mutation testing
2013
Transcriptional Regulation by Nrf2
2017 Standout
Hypothesis: RNA and DNA Viral Sequence Integration into the Mammalian Host Genome Supports Long-Term B Cell and T Cell Adaptive Immunity
2017 StandoutNobel
Breast cancer
2019 Standout
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
2011
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Mouse embryonic stem cells
2007 StandoutNobel
Randomized Trial of a Decision Aid for Patients with Cystic Fibrosis Considering Lung Transplantation
2009
Glutathione peroxidases
2012 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Unraveling the mechanism of BRCA2 in homologous recombination
2011
Epidemiology of Prostate Cancer
2019 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Selenium and human health
2012 Standout
Inherited Susceptibility to Common Cancers
2008
Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
2014
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction.
2009
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand
2011
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
2010
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Arsenic and selenium toxicity and their interactive effects in humans
2014
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
2021 Standout
The Top 10 fungal pathogens in molecular plant pathology
2012 Standout
Current and future burden of breast cancer: Global statistics for 2020 and 2040
2022 Standout
<p>Epidemiological characteristics of and risk factors for breast cancer in the world</p>
2019
An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair
2009 StandoutNobel
Genome editing with engineered zinc finger nucleases
2010 Standout
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Hepatocellular carcinoma
2022 Standout
Selenium in Human Health and Disease
2010
DNA Damage and Repair: From Molecular Mechanisms to Health Implications
2008
Selenium in the Environment, Metabolism and Involvement in Body Functions
2013 Standout
Mechanism of Eukaryotic Homologous Recombination
2008
PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
2012
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Ovarian Cancer Prevention in High-risk Women
2017
Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2
2014
<p>A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of <em>BRCA</em>-mutated breast cancer</p>
2019
Cancer statistics for the year 2020: An overview
2021 Standout
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
2010 Standout
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
2013
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Cloud Computing-Based Framework for Breast Cancer Diagnosis Using Extreme Learning Machine
2021 Standout
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement.
2015
GermlineBRCAMutations Denote a Clinicopathologic Subset of Prostate Cancer
2010
Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 Carriers
2010
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Works of Aletta Poll being referenced
A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.
2007
A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing
2013
Rapid progression of prostate cancer in men with a BRCA2 mutation
2008
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
2008
Patient satisfaction and cancer‐related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2
2010
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening
2012
Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
2007
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation
2007
Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers
2010
Analysis ofPALB2/FANCN-associated breast cancer families
2007
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
2009